Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Pre-transfusion screening for platelet-reactive antibodies.

Tasaki T, Fujii K, Gotoh K, Satoh S, Takadate J, Sasaki S, Kamitsukue M, Yamamoto K, Suwabe A.

Transfus Apher Sci. 2005 Oct;33(2):157-64.

PMID:
16139570
2.

[Introduction of platelet additive solution in platelet concentrates: towards a decrease of blood transfusion reactions].

Rebibo D, Simonet M, Hauser L.

Transfus Clin Biol. 2008 Nov;15(5):289-93. doi: 10.1016/j.tracli.2008.09.016. Epub 2008 Oct 18. French.

PMID:
18930424
4.

Bacterial screening of platelet concentrates: results of 2 years active surveillance of transfused positive cultured units released as negative to date.

Koopman MM, van't Ende E, Lieshout-Krikke R, Marcelis J, Smid WM, de Korte D.

Vox Sang. 2009 Nov;97(4):355-7. doi: 10.1111/j.1423-0410.2009.01221.x. Epub 2009 Aug 4.

PMID:
19682347
5.
6.

Universal adoption of pathogen inactivation of platelet components: impact on platelet and red blood cell component use.

Osselaer JC, Doyen C, Defoin L, Debry C, Goffaux M, Messe N, Van Hooydonk M, Bosly A, Lin JS, Lin L, Corash L.

Transfusion. 2009 Jul;49(7):1412-22. doi: 10.1111/j.1537-2995.2009.02151.x. Epub 2009 Mar 31.

PMID:
19389022
7.
8.

Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy.

Akkök CA, Brinch L, Lauritzsen GF, Solheim BG, Kjeldsen-Kragh J.

Vox Sang. 2007 Jul;93(1):42-8.

PMID:
17547564
9.

Platelets do not adsorb HLA class I molecules during storage of pooled platelet concentrates.

Zeiler T, Heim M, Dempfle A, Kretschmer V.

Transfus Med. 2006 Jun;16(3):176-83.

PMID:
16764596
10.

Cost-effectiveness of pathogen inactivation for platelet transfusions in the Netherlands.

Postma MJ, van Hulst M, De Wolf JT, Botteman M, Staginnus U.

Transfus Med. 2005 Oct;15(5):379-87.

PMID:
16202052
11.

[The quality of platelet concentrates in dependence on storage time before pathogen inactivation].

Bujno M, Lipska A, Zebrowska A, Wróbel J, Gawrylak-Dryja E, Nedzi M, Radziwon P.

Pol Merkur Lekarski. 2011 Mar;30(177):187-90. Polish.

PMID:
21544995
12.

Significance of platelet-reactive antibody screening for patients facing frequent platelet transfusions.

Tasaki T, Fujii K, Gotoh K, Satoh S, Takadate J, Sasaki S, Tachibana M, Yamamoto K.

Immunohematology. 2002;18(4):104-8.

PMID:
15373546
13.

Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets.

Schrezenmeier H, Walther-Wenke G, Müller TH, Weinauer F, Younis A, Holland-Letz T, Geis G, Asmus J, Bauerfeind U, Burkhart J, Deitenbeck R, Förstemann E, Gebauer W, Höchsmann B, Karakassopoulos A, Liebscher UM, Sänger W, Schmidt M, Schunter F, Sireis W, Seifried E.

Transfusion. 2007 Apr;47(4):644-52.

PMID:
17381623
14.

Propionibacterium acnes lacks the capability to proliferate in platelet concentrates.

Störmer M, Kleesiek K, Dreier J.

Vox Sang. 2008 Apr;94(3):193-201. Epub 2007 Dec 11.

PMID:
18086288
15.

[Improvement in cryopreservation of blood platelets].

Zhiburt EB, Vil'ianinov VN, Kaleko SP, Sidorkevich SV, Petrenko GI, Bagautdinov ShM, Kuz'min NS.

Med Tekh. 2000 Jan-Feb;(1):45-7. Russian.

PMID:
10740789
16.

An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatment.

Osselaer JC, Cazenave JP, Lambermont M, Garraud O, Hidajat M, Barbolla L, Tardivel R, Defoin L, Waller C, Mendel I, Raidot JP, Kandel G, De Meuter R, Fabrigli P, Dehenau D, Arroyo JL, Padrón F, Gouezec H, Corral M, Jacquet M, Sundin D, Lin L, Corash L.

Vox Sang. 2008 May;94(4):315-23. doi: 10.1111/j.1423-0410.2007.01035.x. Epub 2008 Jan 30.

PMID:
18248574
17.
18.

Effects of skin disinfection method, deviation bag, and bacterial screening on clinical safety of platelet transfusions in the Netherlands.

de Korte D, Curvers J, de Kort WL, Hoekstra T, van der Poel CL, Beckers EA, Marcelis JH.

Transfusion. 2006 Mar;46(3):476-85.

PMID:
16533293
19.

Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation.

Gurkan E, Patah PA, Saliba RM, Ramos CA, Anderson BS, Champlin R, de Lima M, Lichtiger B.

Bone Marrow Transplant. 2007 Sep;40(5):461-4. Epub 2007 Jun 25.

PMID:
17589530
20.

Frequency of bacterial contamination of platelet concentrates before and after introduction of diversion method in Japan.

Satake M, Mitani T, Oikawa S, Nagumo H, Sugiura S, Tateyama H, Awakihara S, Mitsutomi Y, Muraoka M, Tadokoro K.

Transfusion. 2009 Oct;49(10):2152-7. doi: 10.1111/j.1537-2995.2009.02243.x. Epub 2009 Jun 4.

PMID:
19500321

Supplemental Content

Support Center